Lene Ringholm

Lene Ringholm serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Based at Blegdamsvej 3, 2200 Copenhagen N, Denmark, she maintains active clinical-academic engagement with professional correspondence via lene.ringholm.02@regionh.dk. Her institutional affiliation bridges Rigshospitalet (Copenhagen University Hospital) and the university's medical faculty, reflecting her translational research focus.

Dr. Ringholm's primary research centers on optimizing diabetes management during pregnancy, with specialized expertise in Type 1 Diabetes care throughout gestation, labor, and delivery. She investigates insulin delivery systems including pump therapy and automated insulin delivery, evaluates continuous glucose monitoring metrics, and examines predictors of adverse fetal outcomes such as large-for-gestational-age infants. Her work extends to diagnostic protocols for gestational diabetes and national registry development for pregnancy outcomes in diabetic populations, demonstrating clinical commitment to improving maternal-fetal health through evidence-based interventions.

Analysis of her 13 recent publications (2024-2025) reveals concentrated expertise in diabetes-pregnancy interfaces, with 80% of outputs directly addressing Type 1 Diabetes management during gestation. Key collaborative projects include the CopenFast trial comparing insulin aspart variants and the Danish Diabetes Birth Registry 2 tracking national pregnancy outcomes. Her research consistently bridges clinical endocrinology and obstetrics, emphasizing real-world applicability through secondary analyses of randomized trials and protocol development for large-scale cohort studies.

No scientific awards were documented in the provided materials.

Information regarding academic advising responsibilities or secured research grants was not present in the source documentation.

Dr. Ringholm participates in significant multi-institutional collaborations including the CopenFast trial investigating insulin therapies in pregnancy and the Danish Diabetes Birth Registry 2 initiative. These projects involve national clinical networks across Danish maternity units, facilitating translational research from clinical trials to population-level registry data. Her work demonstrates integration within Denmark's specialized diabetes-pregnancy research infrastructure, contributing to both technological innovation in glucose monitoring and standardized outcome tracking for diabetic pregnancies.